Sunday, November 7, 2021
- 8:30AM-10:30AM
-
Abstract Number: 0626
Does Higher Quality of Care in SLE Translate to Better Patient Outcomes?
Measures & Measurement of Healthcare Quality Poster (0623–0659)- 8:30AM-10:30AM
-
Abstract Number: 0902
Does Imaging of the Sacroiliac Joint and Spine Differ in Patients Presenting with Undiagnosed Back Pain and Psoriasis, Acute Anterior Uveitis, and Colitis: An Inception Cohort Study
Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster II: Imaging in Spondyloarthritis (0897–0907)- 8:30AM-10:30AM
-
Abstract Number: 0864
Does Obesity Affect Disease Activity Outcomes in Systemic Lupus Erythematosus?
SLE – Diagnosis, Manifestations, & Outcomes Poster II: Manifestations (0855–0896)- 8:30AM-10:30AM
-
Abstract Number: 0672
Does Obesity Affect Gout Risk Differently Among Genetically Predisposed Individuals?: Sex-Specific Prospective Cohort Study Findings over >32 Years
Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I (0660–0682)- 8:30AM-10:30AM
-
Abstract Number: 0724
Dose (Exposure) Efficacy Response of Tanezumab Following Intravenous and Subcutaneous Administration Across Phase 2 and Phase 3 Studies in Patients with Osteoarthritis of Hip and Knee
Osteoarthritis – Clinical Poster II (0723–0738)- 8:30AM-10:30AM
-
Abstract Number: 0911
Drug Retention of Tumor Necrosis Factors and IL-17 Inhibitors in Axial Spondyloarthritis: A Multi-Center Comparative Analysis
Spondyloarthritis Including PsA – Treatment Poster I: Axial Spondyloarthritis (0908–0939)- 8:30AM-10:30AM
-
Abstract Number: 0516
Dual Fibroblast Transdifferentiation Mediated by Type I Interferon: Application to Anti-Ro Mediated Congenital Heart Block
Cytokines & Cell Trafficking Poster (0508–0516)- 8:30AM-10:30AM
-
Abstract Number: PP04
Dual Roles: Thriving with SLE as a Medical Student
Patient Perspectives Poster (PP01–PP09)- 8:30AM-10:30AM
-
Abstract Number: 0530
Dysregulation of IGFI/IGF1R Pathway and IGF1R+3179A/G Polymorphism in Pathogenesis of Sjögren’s Syndrome
Genetics, Genomics & Proteomics Poster (0517–0533)- 8:30AM-10:30AM
-
Abstract Number: 0931
Early Improvement in Disease Activity Indices Predicts Achievement of Long-term Clinical Remissions, ASDAS Inactive Disease and Low BASDAI with Normal CRP, During TNF-α-inhibitor Therapy in Patients with Ankylosing Spondylitis
Spondyloarthritis Including PsA – Treatment Poster I: Axial Spondyloarthritis (0908–0939)- 8:30AM-10:30AM
-
Abstract Number: 0801
Early Remission at 6 Months as a Predictor of Longterm Remission in New Onset Rheumatoid Arthritis
RA – Diagnosis, Manifestations, & Outcomes Poster II: Miscellaneous Aspects of RA (0786–0812)- 8:30AM-10:30AM
-
Abstract Number: 0669
Early-Onset Gout (EOG) Patients Are an Important and Recalcitrant Phenotype Warranting Further Investigation: A Systematic Review
Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I (0660–0682)- 8:30AM-10:30AM
-
Abstract Number: 0881
Economic Evaluation of Neuropsychiatric (NP) Lupus in an International Inception Cohort Using a Multistate Model Approach
SLE – Diagnosis, Manifestations, & Outcomes Poster II: Manifestations (0855–0896)- 8:30AM-10:30AM
-
Abstract Number: 0858
Effect of COVID Infection and COVID Vaccination on SLE Activity, Including Antiphospholipid Antibodies